Clinical Trial Update: Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial [Phase 2]

View source ↗

Summary

A single-arm Phase II trial evaluated Temozolomide in relapsed or advanced anaplastic oligodendroglioma and anaplastic oligoastrocytoma. The study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Oligoastrocytoma
• Anaplastic Oligodendroglioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma | Phase 2 | Status: COMPLETED